BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 191371)

  • 21. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of antibodies to Epstein-Barr virus-induced early antigens in Burkitt's lymphoma. Comparison of dying patients with long-term survivors.
    Henle W; Henle G; Gunvén P; Klein G; Clifford P; Singh S
    J Natl Cancer Inst; 1973 May; 50(5):1163-73. PubMed ID: 4351392
    [No Abstract]   [Full Text] [Related]  

  • 23. Epstein-Barr virus infection in relation to infectious mononucleosis and Burkitt's lymphoma.
    Smith RT; Bausher JC
    Annu Rev Med; 1972; 23():39-56. PubMed ID: 4345525
    [No Abstract]   [Full Text] [Related]  

  • 24. The frequency of Epstein-Barr virus infection and Burkitt's lymphoma at high and low altitudes in East Africa.
    Geser A; Brubaker G; Olwit GW
    Rev Epidemiol Sante Publique; 1980 Oct; 28(3):307-21. PubMed ID: 6258200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of delayed hypersensitivity reactions to lymphoid cell lines and antibodies to Epstein-Barr virus.
    Levine PH; Ho JH; Nkrumah F; Andrese AP
    IARC Sci Publ (1971); 1978; (24 Pt 2):893-8. PubMed ID: 221411
    [No Abstract]   [Full Text] [Related]  

  • 26. Strong correlations of anti-viral capsid antigen antibody levels in first-degree relatives from families with Epstein-Barr virus-related lymphomas.
    Besson C; Amiel C; Le-Pendeven C; Plancoulaine S; Bonnardel C; Ranque B; Abbed K; Brice P; Fermé C; Carde P; Hermine O; Raphael M; Bresson JL; Nicolas JC; Gessain A; Dethe G; Abel L
    J Infect Dis; 2009 Apr; 199(8):1121-7. PubMed ID: 19284285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to Epstein-Barr virus (EBV) antigens in sera of American Burkitt lymphoma patients.
    Ablashi DV; De-Thé GB; Easton JM; Liabeuf A; Levine PH; Armstrong GR
    Biomedicine; 1974 Jul; 21(7):288-93. PubMed ID: 4139981
    [No Abstract]   [Full Text] [Related]  

  • 28. [Burkitt's lymphoma-Epstein-Barr virus association in western Algeria. Clinical, cytological and serological aspects apropos of 34 pediatric cases].
    Meziane F; Aguercif M; Chevallier A; Lavoue MF; Boukli H; Mehadji M; Boughermouh M
    Pediatrie; 1985 Mar; 40(2):87-98. PubMed ID: 3001633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EVB-associated immune complexes and recurrent Burkitt's lymphoma.
    Gunven P; Klein G; Rosen A; Mukojima T
    IARC Sci Publ (1971); 1978; (24 Pt 2):875-82. PubMed ID: 221409
    [No Abstract]   [Full Text] [Related]  

  • 30. Epstein-Barr virus-associated Burkitt's lymphoma in India.
    Venkitaraman AR; John TJ; Rangad F; Singh AD; Date A; Lenoir G
    Trop Geogr Med; 1983 Sep; 35(3):273-7. PubMed ID: 6316592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune complexes associated with neoplasia: presence of Epstein-Barr virus antigen-antibody complexes in Burkitt's lymphoma.
    Oldstone MB; Theofilopoulos AN; Gunvén P; Klein G
    Intervirology; 1974; 4(5):292-302. PubMed ID: 4377147
    [No Abstract]   [Full Text] [Related]  

  • 32. A preliminary report of epidemiological studies of Burkitt's lymphoma, Epstein-Barr virus infection and malaria in North Mara, Tanzania.
    Geser A; Brubaker G
    IARC Sci Publ; 1985; (60):205-15. PubMed ID: 2998990
    [No Abstract]   [Full Text] [Related]  

  • 33. Specific neutralizing antibodies in Epstein-Barr virus associated diseases.
    Rocchi G; Hewetson J; Henle W
    Int J Cancer; 1973 May; 11(3):637-47. PubMed ID: 4364719
    [No Abstract]   [Full Text] [Related]  

  • 34. Historical background; Burkitt's lymphoma and Epstein-Barr virus.
    Epstein MA
    IARC Sci Publ; 1985; (60):17-27. PubMed ID: 2998988
    [No Abstract]   [Full Text] [Related]  

  • 35. Antibodies to the R component of Epstein-Barr virus-induced early antigens in Burkitt's lymphoma exceeding in titer antibodies to Epstein-Barr capsid antigen.
    Henle W; Henie G
    J Natl Cancer Inst; 1977 Mar; 58(3):785-6. PubMed ID: 190417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burkitt's lymphoma cell line bearing surface IgA and negative for nuclear antigen of Epstein-Barr virus (EBNA).
    Hayashi Y; Matsumura Y; Nishihira T; Watanabe I; Ohi R; Kasai M; Kumagai K; Kamada N
    Jpn J Exp Med; 1980 Dec; 50(6):423-34. PubMed ID: 6268866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus and Burkitt lymphoma.
    Lancet; 1978 Sep; 2(8089):561. PubMed ID: 79925
    [No Abstract]   [Full Text] [Related]  

  • 38. Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies.
    Lindahl T; Klein G; Reedman BM; Johansson B; Singh S
    Int J Cancer; 1974 Jun; 13(6):764-72. PubMed ID: 4137165
    [No Abstract]   [Full Text] [Related]  

  • 39. Epstein-Barr virus, infectious mononucleosis, Burkitt's lymphoma and nasopharyngeal carcinoma.
    Klein G
    Isr J Med Sci; 1977 Jul; 13(7):716-24. PubMed ID: 200586
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence for an etiologic relation of the Epstein-Barr virus to human malignancies.
    Henle W; Henle G
    Laryngoscope; 1977 Apr; 87(4 Pt 1):467-73. PubMed ID: 190497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.